Compare Diamond Citra Propertindo Tbk. (DADA) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Diamond Citra Propertindo Tbk. vs UBC Medical Indonesia Tbk. — how do they compare? Diamond Citra Propertindo Tbk. trades at Rp50 (market cap 371.58B, 215.4K 24h volume), while UBC Medical Indonesia Tbk. trades at Rp146 (market cap 584.6B, 817.3K 24h volume). The key difference: UBC Medical Indonesia Tbk. is the larger of the two by market cap, and UBC Medical Indonesia Tbk. is more actively traded (817.3K versus 215.4K). Which is the better fit depends on your goals.
| DADA | LABS | |
|---|---|---|
Market Cap | 371.58B | 584.6B |
Volume | 215.4K | 817.3K |
Lot | 2.15K | 8.17K |
Turnover | 10.77M | 120.01M |
Average Price | 50 | 146.84 |
Value | 10.77M | 120.01M |
Indicative Equilibrium Price | 50 | 146 |
Indicative Equilibrium Volume | 31 | 59 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Diamond Citra Propertindo Tbk.
PT. Diamond Citra Propertindo Tbk ("the Company") was established based on Deed of Establishment No. 86 December 29, 2014, by Dewi Kusumawati, S.H., notary in Jakarta.
Read more on DADA →About UBC Medical Indonesia Tbk.
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →
